Emodin improves lipid and glucose metabolism in high fat diet-induced obese mice through regulating SREBP pathway
文献类型：期刊论文
| 作者 | Li, Jinmei1; Ding, Lili1,4; Song, Baoliang2; Xiao, Xu2; Qi, Meng1; Yang, Qiaoling1; Yang, Qiming1; Tang, Xiaowen1; Wang, Zhengtao1; Yang, Li1,3 |
| 刊名 | European journal of pharmacology
 |
| 出版日期 | 2016-01-05 |
| 卷号 | 770页码:99-109 |
| ISSN号 | 1879-0712 |
| DOI | 10.1016/j.ejphar.2015.11.045 |
| 文献子类 | Article |
| 英文摘要 | Currently, obesity has become a worldwide epidemic associated with Type 2 diabetes, dyslipidemia, cardiovascular disease and chronic metabolic diseases. Emodin is one of the active anthraquinone derivatives from Rheum palmatum and some other Chinese herbs with anti-inflammatory, anticancer and hepatoprotective properties. In the present study, we investigated the anti-obesity effects of emodin in obese mice and explore its potential pharmacological mechanisms. Male C57BL/6 mice were fed with high-fat diet for 12 weeks to induce obesity. Then the obese mice were divided into four groups randomly, HFD or emodin (40mg/kg/day and 80mg/kg/day) or lovastatin (30mg/kg/ day) for another 6 weeks. Body weight and food intake were recorded every week. At the end of the treatment, the fasting blood glucose, glucose and insulin tolerance test, serum and hepatic lipid levels were assayed. The gene expressions of liver and adipose tissues were analyzed with a quantitative PCR assay. Here, we found that emodin inhibited sterol regulatory element-binding proteins (SREBPs) transactivity in huh7 cell line. Furthermore, emodin (80mg/kg/day) treatment blocked body weight gain, decreased blood lipids, hepatic cholesterol and triglyceride content, ameliorated insulin sensitivity, and reduced the size of white and brown adipocytes. Consistently, SREBP-1 and SREBP-2 mRNA levels were significantly reduced in the liver and adipose tissue after emodin treatment. These data demonstrated that emodin could improve high-fat diet-induced obesity and associated metabolic disturbances. The underlying mechanism is probably associated with regulating SREBP pathway. |
| 语种 | 英语 |
| 源URL | [http://119.78.100.183/handle/2S10ELR8/266583]  |
| 专题 | 中国科学院上海药物研究所 |
| 通讯作者 | Yang, Li |
| 作者单位 | 1.(a)The Ministry of Education (MOE) Key Laboratory for Standardization of Chinese Medicines, the State Administration of TCM (SATCM) Key Laboratory for New Resources and Quality Evaluation of Chinese Medicine, Shanghai Key Laboratory of Complex Prescriptions, Institute of Chinese Materia Medica, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China; 2.The State Key Laboratory of Molecular Biology, Institute of Biochemistry and Cell Biology, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, Shanghai 200031, China; 3.Center for Chinese Medical Therapy and Systems Biology, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China 4.Center for Chinese Medical Therapy and Systems Biology, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China; |
| 推荐引用方式 GB/T 7714 | Li, Jinmei,Ding, Lili,Song, Baoliang,et al. Emodin improves lipid and glucose metabolism in high fat diet-induced obese mice through regulating SREBP pathway[J]. European journal of pharmacology,2016,770:99-109. |
| APA | Li, Jinmei.,Ding, Lili.,Song, Baoliang.,Xiao, Xu.,Qi, Meng.,...&Yang, Li.(2016).Emodin improves lipid and glucose metabolism in high fat diet-induced obese mice through regulating SREBP pathway.European journal of pharmacology,770,99-109. |
| MLA | Li, Jinmei,et al."Emodin improves lipid and glucose metabolism in high fat diet-induced obese mice through regulating SREBP pathway".European journal of pharmacology 770(2016):99-109. |
入库方式： OAI收割
来源：上海药物研究所
浏览0
下载0
收藏0
其他版本
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。